HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marwa A Fouad Selected Research

Cognitive Dysfunction

3/2024Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer's disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation.
1/2023Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
1/2020New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marwa A Fouad Research Topics

Disease

5Neoplasms (Cancer)
12/2023 - 10/2019
4Alzheimer Disease (Alzheimer's Disease)
03/2024 - 01/2020
3Cognitive Dysfunction
03/2024 - 01/2020
2Type 2 Diabetes Mellitus (MODY)
06/2024 - 04/2024
2Kidney Neoplasms (Kidney Cancer)
12/2023 - 01/2021
1Inflammation (Inflammations)
06/2024
1Diabetic Retinopathy (Retinopathy, Diabetic)
06/2024
1Diabetes Mellitus
04/2024
1Breast Neoplasms (Breast Cancer)
12/2023
1Carcinoma (Carcinomatosis)
01/2022
1Leukemia
12/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1Edema (Dropsy)
12/2019
1Chronic Obstructive Pulmonary Disease (COPD)
06/2019

Drug/Important Bio-Agent (IBA)

3LigandsIBA
04/2024 - 01/2020
3Scopolamine (Hyoscine)FDA Link
03/2024 - 01/2020
2AcetylcholinesteraseIBA
12/2023 - 01/2020
2Amyloid (Amyloid Fibrils)IBA
12/2023 - 01/2020
2Donepezil (Aricept)FDA LinkGeneric
01/2023 - 01/2020
2OxindolesIBA
12/2021 - 01/2021
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2024
1Retinaldehyde (Retinal)IBA
06/2024
1Lipid NanoparticlesIBA
06/2024
1VildagliptinIBA
06/2024
1GlucosidasesIBA
04/2024
1Carbonic Anhydrase IIIBA
04/2024
1BenzenesulfonamidesIBA
04/2024
1EnzymesIBA
04/2024
1Glycogen Synthase (Synthase I)IBA
03/2024
1Cytostatic AgentsIBA
12/2023
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2023
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2023
1Cysteine (L-Cysteine)FDA Link
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Tubulin ModulatorsIBA
01/2022
1SulfonamidesIBA
12/2021
1benzenesulfonic acid (benzenesulfonate)IBA
12/2021
1Phosphotransferases (Kinase)IBA
12/2021
1Antineoplastic Agents (Antineoplastics)IBA
12/2021
1Sunitinib (Sutent)FDA Link
01/2021
1phosphazineIBA
01/2020
13'-azido-2',3'-dideoxythymidine 5'-H-phoshonateIBA
01/2020
1ProdrugsIBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2019
1RoflumilastIBA
06/2019

Therapy/Procedure

1Glycemic Control
06/2024